On 8 and 9 October, the international Precision Medicine Networking Forum PMNET Forum 2026 took place at the National Library of Latvia in Riga, bringing...
In October, CPHI Milan 2026 took place in Milan, Italy – one of the world’s leading events for the pharmaceutical industry, bringing together more than...
JSC Grindeks has invested €1.87 million in a new packaging line at JSC Tallinna Farmaatsiatehas. During its first eight months of operation, the line produced...
JSC Grindeks’ subsidiary in Lithuania Ltd Grindeks Kalceks has received the “Strongest in Lithuania 2026” (Stipriausi Lietuvoje) recognition, confirming the company’s financial stability, reliability and...
JSC Grindeks is pleased to announce a significant milestone in its product portfolio expansion: the successful registration of betamethasone valerate cream in the United Kingdom....
On March 26, one of the most significant events in the Latvian healthcare sector, the ceremonial “Medical Excellence Awards” took place at the Splendid Palace...
Over the last decade, Grindeks has been focusing on its own brand portfolio, but under the new CEO we are shifting our business development strategy....
Changes have taken place in the Management Board of JSC Grindeks – Jānis Romanovskis has been appointed as the company’s Chairman of the Board. Romanovskis’...
Financial results for “Grindeks” show that in the first half of 2025 – the company’s final year of transformation – the Group has achieved significant...
